With Oncology Drugs On The Way, AstraZeneca Sets The Stage For New Launches
Executive Summary
U.S. President Paul Hudson says AstraZeneca is building specialty commercial team ahead of new oncology launches; MedImmune seals new deals in its quest for winning combinations in immuno-oncology.